Details of the Drug Formulaction

General Information of Drug Formulation (ID: F05273)

• Formulation Name: Dasatinib 50 mg tablet
• Company: E.R. Squibb & Sons

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Dasatinib	(DMJV2EK)	Blast phase chronic myelogenous leukemia, BCR-ABL1 positive		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent